15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Innospec Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $93.00 to $93.00, so the covering firms are broadly aligned. The average target of $93.00 sits 9% above the current $85.64. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.26 next quarter toward $6.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Innospec Inc.
As of Jul, 1 of 1 firms rate IOSP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IOSP EPS & revenue forecast
EPS · NEXT QUARTER
$1.26
Range $1.25 – $1.26 · 3 analysts · +12% YoY
Next period, 3 analysts expect Innospec Inc to earn $1.26 a share (range $1.25 – $1.26), versus $1.12 a year earlier. Full-year consensus is $4.81, growing to $6.08 the year after.
REVENUE · NEXT QUARTER
$471.6M
Range $458.0M – $478.7M · 3 analysts · +7% YoY
Revenue is expected to reach $471.6M (range $458.0M – $478.7M), +6.7% year-over-year. Full-year consensus is $1.9B, rising to $2.0B next year.
Top analysts covering Innospec Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IOSP.
#1
DS
David Silver
Freedom Capital Markets
Buy
$93.00+8.6% to target
Coverage
—
+ Follow
#2
MJ
Michael J. Harrison
Seaport Global
Buy
$155.00+81.0% to target
Coverage
—
+ Follow
IOSP stock forecast FAQ
What is IOSP's average 12-month price target?+
The 1 analysts with a live target average $93.00 for Innospec Inc over the next 12 months, ranging from a $93.00 high to a $93.00 low.
Is IOSP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover IOSP?+
1 analysts have an active rating on Innospec Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering IOSP?+
Among analysts who currently cover IOSP, David Silver of Freedom Capital Markets has the strongest overall Quantellect track record. Their current call is Buy with a $93.00 target.
What is Innospec Inc's projected EPS for next quarter?+
The consensus estimate is $1.26 per share (range $1.25 – $1.26) across 3 analysts. Full-year EPS is projected at $4.81, rising to $6.08 the following year.
How much revenue is Innospec Inc expected to report next quarter?+
Consensus revenue is $471.6M (range $458.0M – $478.7M). Full-year revenue is projected at $1.9B, growing to $2.0B next year.
Have analysts been upgrading or downgrading IOSP lately?+
As of Jul, 1 of 1 firms rate IOSP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IOSP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
